Hostname: page-component-74656f9884-2dmjx Total loading time: 0 Render date: 2026-11-06T22:20:12.610Z Has data issue: false hasContentIssue false

Surgical treatment of marked mitral valvar deformity combined with I-cell disease ‘Mucolipidosis II’

Published online by Cambridge University Press:  16 September 2005

Masahiro Daimon
Affiliation:
Department of Pediatric Cardiovascular Surgery, Children's Research Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan
Masaaki Yamagishi
Affiliation:
Department of Pediatric Cardiovascular Surgery, Children's Research Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan
Rights & Permissions [Opens in a new window]

Abstract

I-cell disease is a rare, hereditary, and fatal disease, which is often complicated with disease of the cardiac valves. We have experienced a case of severe mitral valvar insufficiency in a 9-month-old male infant with I-cell disease. Mitral valvoplasty was difficult, because the leaflets were remarkably hypertrophic, and the tendinous cords were elongated and adherent. Despite these difficulties, surgery proved effective in the treatment of the congestive heart failure, allowing for further treatment of the I-cell disease.

Information

Type
Brief Report
Copyright
© 2005 Cambridge University Press
Figure 0

(a) Preoperative echocardiography showing marked thickening of both leaflets of the mitral valve (arrow). LA: left atrium; LV: left ventricle. (b) Resected mitral valve showing thickening of both leaflets and adhesion of tendinous cords. AML: aortic mitral leaflet MML: mural mitral leaflet.

Figure 1

Photomicrograph of degenerative mitral valve showing mucinous deposits with swollen mononuclear cells. Hematoxylin and eosin. ×20.